newsfilter
← Latest News
Bloomberg·

Biotech Analyst Porges Sounds Regulatory Alarm on Drugmakers

Biotech analysts are usually a bullish bunch, anticipating scientific breakthroughs that will send stocks surging. But SVB Leerink’s Geoffrey Porges has broken from the pack, with cautious recommendations outweighing the number of companies he sees as buys.